SEO-ABM

In vivo module

Stage III


In vivo animal studies
Eye drops containing a new medicinal product or a new type of carrier cannot be administered to the human eye without prior assessment of their safety and efficacy following administration to an animal eye. Accordingly, before the formulation proceeds to clinical trials in humans, it will be administered to the eyes of pigs, whose ocular anatomy is among the most similar to that of humans. This stage has already been preceded by safety studies in cell cultures (in vitro) and studies of the carrier alone (placebo) in rabbits.

Logo Instytutu Fizjologii i Żywienia Zwierząt im. Jana Kielanowskiego PAN

Cooperation has already been established with the Institute of Animal Nutrition and Physiology of the Polish Academy of Sciences, and approval for the studies has been obtained from the Bioethics Committee. Experiments will begin shortly to assess ocular tolerability of the innovative suspension formulations administered over three days. Ocular responses to the new formulation will be compared with those to conventional aqueous eye drops containing antibiotics in solution. An attempt will also be made to treat naturally occurring eye infections in animals using the two types of drops, in order to establish the antibacterial efficacy of the new formulation.

SEO-ABM
SEO-ABM
SEO-ABM
SEO-ABM